Andrew Forrest-backed biotech in peanut allergy breakthrough
A Melbourne-based biotech backed by billionaire Andrew Forrest says it has successfully tested a monthly injection to help children with peanut allergies safely build up a tolerance to the lethal condition. Aravax, funded by Forrest’s venture capital fund …